Agilent Technologies Inc at Goldman Sachs CEOs Unscripted Conference Transcript

Jan 05, 2023 / 07:05PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

All right. Good afternoon, everyone. I'm Matt Sykes, the Life Sciences Tools and Diagnostics analyst at Goldman Sachs. And today, we have the pleasure of kicking off the new year with Agilent, Mike McMullen, CEO; and Bob McMahon, CFO. Mike, Bob, thanks for joining us today.

Robert W. McMahon - Agilent Technologies, Inc. - Senior VP & CFO

Thanks, Matt.

Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director

Thanks, Matt. Happy new year to you and to your clients. And I must say, it's great to be here in a face-to-face environment again.

Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

Certainly is. It certainly is.

Questions and Answers:

Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

Maybe we'll start off just kind of -- I'll
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot